Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Effectiveness and Safety of Acupuncture for Obesity and Over-weight People

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02108236
Recruitment Status : Unknown
Verified March 2015 by Wang Ling Shu, Heilongjiang University of Chinese Medicine.
Recruitment status was:  Recruiting
First Posted : April 9, 2014
Last Update Posted : March 26, 2015
Sponsor:
Information provided by (Responsible Party):
Wang Ling Shu, Heilongjiang University of Chinese Medicine

Brief Summary:
To determine the efficacy and safety of acupuncture for obesity and overweight people in China.

Condition or disease Intervention/treatment Phase
Obesity Overweight Device: acupuncture Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 110 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Treatment
Study Start Date : May 2014
Estimated Primary Completion Date : October 2015

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Acupuncture

Arm Intervention/treatment
No Intervention: Blank control group
A control group of patients is put on a waiting list for no intervention and remaining unchanged lifestyle.
Active Comparator: intervention group
An intervention group of patients is put on a waiting list for acupuncture treatment.
Device: acupuncture
Zhong-wan (RN12), Liang-men (ST21), Shui-fen (RN9) and Qi-hai (RN6) and bilateral acupuncture points Dai-mai (GB26), Tian-shu (ST25), Zu-sanli (ST36), Feng-long(ST40) and Liang-qiu(ST34) will be applied through the skin by acupuncture for 30 minutes every time. Electro-acupuncture apparatus will be connected to both Dai-mai, Zu-sanli and Feng-long, Zhong-wan and Qi-hai for 30 minutes with interrupted waves (2/100HZ).




Primary Outcome Measures :
  1. body mass index(BMI) [ Time Frame: 2 month after treatment ]

Secondary Outcome Measures :
  1. waist-to-hip ratio (WHR) [ Time Frame: 2 month after treatment ]
  2. Blood sugar [ Time Frame: 2 month after treatment ]
  3. Total cholesterol [ Time Frame: 2 month after treatment ]
  4. Triglycerides [ Time Frame: 2 month after treatment ]
  5. High-density lipoprotein cholesterol [ Time Frame: 2 month after treatment ]
  6. Low-density lipoprotein cholesterol [ Time Frame: 2 month after treatment ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 45 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • The individuals is phlegm-dampness constitution and female.
  • Age is between 18 and 45 years.
  • BMI is between 24 and 50.
  • The individuals voluntarily sign the informed consent form.
  • The individuals live in Harbin City of China.

Exclusion Criteria:

  • Secondary obesity, eg:pituitary diseases, hypothalamic disorder, hypothyroidism, pancreatic diseases,hyperadrenocorticism, postmenopausal obesity etc.
  • The individuals with server cardiovascular and cerebrovascular diseases and cancer.
  • Having therapy for obesity in the last three months.
  • The individuals do not adhere to the treatment or are with other treatments.
  • Female individuals with pregnancy, lactation and planning a pregnancy in the two months.
  • Critical patients or patients combined with liver and kidney damage.
  • Individuals with visual and auditory memory disorders or psychosis.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02108236


Contacts
Layout table for location contacts
Contact: Xie Ning, PhD 086 045182111401 xiening2014@163.com

Locations
Layout table for location information
China, Heilongjiang
The First Affiliated Hospital of Heilongjiang University of Chinese Medicine Recruiting
Harbin, Heilongjiang, China, 150040
Sponsors and Collaborators
Heilongjiang University of Chinese Medicine
Investigators
Layout table for investigator information
Principal Investigator: Sun Zhongren First Affiliated Hospital of Heilongjiang Chinese Medicine University

Layout table for additonal information
Responsible Party: Wang Ling Shu, the head of institute of chinese medicine and translational science of First Affiliated Hospital, Heilongjiang University of Chinese Medicine
ClinicalTrials.gov Identifier: NCT02108236     History of Changes
Other Study ID Numbers: Acupuncture-Obesity-2014-3
First Posted: April 9, 2014    Key Record Dates
Last Update Posted: March 26, 2015
Last Verified: March 2015

Keywords provided by Wang Ling Shu, Heilongjiang University of Chinese Medicine:
acupuncture
chinese traditional medicine

Additional relevant MeSH terms:
Layout table for MeSH terms
Obesity
Overweight
Overnutrition
Nutrition Disorders
Body Weight
Signs and Symptoms